Xu, H; Lv, M; Tian,X (2009). “A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.”. Curr. Med. Chem.16 (3): 327–349. doi:10.2174/092986709787002682. PMID19149581.
J. L. Hartwell, A. W. Schrecker (1951). “Components of Podophyllin. V. The Constitution of Podophyllotoxin”. J. Am. Chem. Soc.73 (6): 2909–2916. doi:10.1021/ja01150a143.
Borsche, W.; Niemann J. (1932). “Über Podophyllin”. Justus Liebigs Ann. Chem.494: 126–142. doi:10.1002/jlac.19324940113.
You, Y (2005). “Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents.”. Curr. Pharm. Des.11 (13): 1695–1717. doi:10.2174/1381612053764724. PMID15892669.
Xu, H; Lv, M; Tian,X (2009). “A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.”. Curr. Med. Chem.16 (3): 327–349. doi:10.2174/092986709787002682. PMID19149581.
You, Y (2005). “Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents.”. Curr. Pharm. Des.11 (13): 1695–1717. doi:10.2174/1381612053764724. PMID15892669.
Damayanthi Y, Lown JW (June 1998). “Podophyllotoxins: current status and recent developments”. Curr. Med. Chem.5 (3): 205–52. PMID9562603.
Xie FM, Zeng K, Chen ZL, et al. (2007). “Treatment of recurrent condyloma acuminatum with solid lipid nanoparticle gel containing podophyllotoxin: a randomized double-blinded, controlled clinical trial” (Chinese). Nan Fang Yi Ke Da Xue Xue Bao27 (5): 657–9. PMID17545082.